Home » Celsion Scores Patent for Delivery System
Celsion Scores Patent for Delivery System
Celsion received U.S. patent protection covering its lung-specific delivery system, TheraSilence.
The patent covers TheraSilence compositions and delivery forms in a range of therapeutic RNA entities.
“Our strategy is to seek to maximize the value of this platform in the near-term by pursuing collaborations and development agreements, while focusing internal development efforts on our two clinical stage candidates, ThermoDox and GEN-1, our DNA-based immunotherapy for the localized treatment of ovarian cancer,” Michael Targundo, chairman, president and CEO of Celsion, said in a prepared statement. — Anisa Jibrell
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May